EU antitrust regulators will decide by Dec. 7 whether to clear US medical device company Thermo Fisher Scientific’s $21 billion bid for contract research firm PPD, a European Commission filing showed on Wednesday.
Thermo Fisher, the world’s largest maker of scientific instruments, announced the deal in April. The contract research industry is rebounding from pandemic disruption amid growing demand for virtual clinical trials.
The European Commission can clear the deal with or without concessions at the end of its preliminary review or it can open a four-month long investigation if it has serious concerns.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Athletes Behind NCAA Antitrust Settlement Push for Collective Bargaining Rights
Dec 11, 2024 by
CPI
Big Tech Stocks Surge as Trump Names Ferguson to Lead FTC
Dec 11, 2024 by
CPI
Synopsys Proposes Divestitures to Secure EU Approval for $35 Billion Ansys Deal
Dec 11, 2024 by
CPI
Renowned Antitrust Expert and Former Morgan Lewis Chair John Shenefield Passes Away
Dec 11, 2024 by
CPI
Trump Taps Mark Meador for Federal Trade Commission Post
Dec 11, 2024 by
CPI
Antitrust Mix by CPI
Coopetition in The Pharma Industry: Challenges for Antitrust
Dec 12, 2024 by
Juan Delgado & Lourdes Sosa
Symmetry and the Sixth Force: The Essential Role of Complements
Dec 12, 2024 by
Adam Brandenburger & Barry Nalebuff
ESG Collaborations in Light of European Antitrust Policy and Enforcement Trends
Dec 12, 2024 by
Christian Ritz, Julia Gingelmaier & Kyra Harmes
Antitrust Chronicle® – Co-opetition
Dec 11, 2024 by
CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI